SciELO - Scientific Electronic Library Online

 
vol.8 número3Osteosarcoma: Pathology, staging and managementProximal humeral allograft in a trauma setting índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • En proceso de indezaciónSimilares en Google

Compartir


SA Orthopaedic Journal

versión On-line ISSN 2309-8309
versión impresa ISSN 1681-150X

SA orthop. j. vol.8 no.3 Pretoria ene. 2009

 

CASE REPORT AND LITERATURE REVIEW

 

Intraneural bleeding of the ulnar nerve in a haemophilic patient: Case report and guide to orthopaedic management

 

 

O KochI; A VisserII

IMBChB(Pret); Registrar, Department of Orthopaedic Surgery, University of Pretoria
IIMBChB(Pret); Registrar, Department Clinical Pathology, University of Pretoria, National Health Laboratory Services

Correspondence

 

 


ABSTRACT

More than 90% of bleeding episodes in patients with haemophilia occur in the musculoskeletal system, of which most episodes occur in the joints. Haematoma formation in muscles, with the development of pseudotumours, may compromise neurovascular structures. The incidence of chronic compressive peripheral neuropathies due to extrinsic causes is low. Acute nerve compression due to intraneural bleeding in patients with haemophilia is a rare entity. We report on acute ulnar nerve compression due to intraneural bleeding, accompanied by median nerve symptoms and present a practical guide to the orthopaedic management of these patients.


 

 

“Full text available only in PDF format”

 

References

1. Walker I, Pai M Akabutu J. The Canadian Hemophilia Registry as the basis for a national system for monitoring the use of factor concentrates. Transfusion 1995;35:548.         [ Links ]

2. Rodriguez-Merchan E. Orthopaedic surgery in persons with haemophilia. Thromb Haemost 2003;89:34-42.         [ Links ]

3. Fernandez-Palazzi F, et al. Hematomas within the iliopsoas muscles in hemophilic patients: the Latin American experience. Clin Orthop 1996 p 19.         [ Links ]

4. Kaymak B, et al. Concomitant compression of median and ulnar nerves in a hemophiliac patient: a case report. Joint Bone Spine 2002;69:611-3.         [ Links ]

5. Hayden J. Median neuropathy in the carpal tunnel caused by spontaneous intraneural hemorrhage. JBJS 1964;46:1242-4.         [ Links ]

6. Cordingley F, Crawford G. Ulnar nerve palsy in a haemophiliac due to intraneural haemorrhage. BMJ 1984;289:18-9.         [ Links ]

7. Greene W. Synovectomy of the ankle for hemophilic arthropathy. JBJS 1994;76-A(6):812-9.         [ Links ]

8. Dumontier C, et al. Entrapment and compartment syndromes of the upper limb in haemophilia. Journal of Hand Surgery (British and European Volume) 1994;19b(4):427-9.         [ Links ]

9. Katz S, et al. Peripheral nerve lesions in hemophililia. JBJS 1991; 73-A(7):1016-9.         [ Links ]

10. Nixon R, Brindley G. Hemophilia presenting as compartment syndrome in the arm following venipuncture. CORR 1989;244:176-81.         [ Links ]

11. Ljung R, Petrini P, Nilsson I. Diagnostic symptoms of severe and moderate haemophilia A and B. A survey of 140 cases. Acta Paediatr Scand 1990;79:196.         [ Links ]

12. Mahlangu J, Gilham A. Guidelines for the treatment of haemophilia in South Africa. SAMJ 2007;97(2):1296-309.         [ Links ]

13. White G, et al. Definitions in hemophilia: recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost 2001;85:560.         [ Links ]

14. Hvid I, Rodriquez-Merchan E. Orthopaedic surgery of haemophilia in the 21st century: an overview. Haemophilia 2002;8:360-8.         [ Links ]

15. Hoyer L, Scandella D. Factor VIII: Structure and function in autoantibody and hemophilia A patients. Semin Hematol 1994;31:1.         [ Links ]

16. Lusher J, et al. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group. N Engl J Med 1993;328:453.         [ Links ]

17. Rasi V, Ikkala E. Haemophiliacs with factor VIII inhibitors in Finland: prevalence, incidence and outcome. Br J Haematol 1990;76:369.         [ Links ]

18. Guidelines for the Management of Hemophilia - World Federation of Hemophilia. www.wfh.org (accessed 17 February 2009), 2005.         [ Links ]

19. D'Young A. Conservative physiotherapeutic management of chronic haematoma and haemophilic pseudotumours: case study and comparison to historical management. Haemophilia 2009;15:253-60.         [ Links ]

20. Gurcay E, et al. A prospective series of musculoskeletal system rehabilitation of arthropathic joints in young male haemophilic patients. Rheumatol Int 2008;28:541-5.         [ Links ]

21. Nilsson I, et al. Twenty-five years experience of prophylactic treatment in severe hemophilia A and B. J Intern Med 1992;232:25-32.         [ Links ]

22. Negrier C, et al. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. Thromb Haemost 1997; 77:1113-9.         [ Links ]

23. Habermann B, et al. Management of haemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VIII and recombinant factor VIIa (NovoSeven): a single centre experience. Haemophilia 2004;10:705-12.         [ Links ]

24. Brinkhous K. Hemophilia. Bull N Y Acad Med 1954;30:325.         [ Links ]

25. Hermens W. Dose calculation of human factor VIII and factor IX concentrates for infusion therapy. In: Brinkhous KM, Hemker HC (eds). Handbook of Hemophilia. New York: American Elsevier Publishing, 1975: p. 569-89.         [ Links ]

26. Hathaway W, et al. Comparison of continuous and intermittent Factor VIII concentrate therapy in hemophilia A. Am J Hematology 1984;17:85-8.         [ Links ]

27. Martinowitz U, et al. Adjusted dose continuous infusion of factor VIII in patients with haemophilia A. Br J Haematol 1992;82:729-34.         [ Links ]

28. Schulman S, Gitel S, Martinowitz U. Stability of factor VIII concentrates after reconstitution. Am J Hematol 1994;45:217-23.         [ Links ]

29. Schulman, S, et al. Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience. Thromb Haemost 1994;72:403-7.         [ Links ]

30. Auer CV, Oldenburg J, Depka MV. Inhibitor development in patients with hemophilia A after continuous infusion of FVIII concentrates. Ann N Y Acad Sci 2005;1051:498-505.         [ Links ]

31. Muchahy R, Walsh M, Scully M. Retrospective audit of a continuous infusion protocol for haemophilia A at a single haemophilia treatment centre. Haemophilia 2005;11:208-15.         [ Links ]

 

 

Correspondence:
Dr O Koch
Department of Orthopaedic Surgery
University of Pretoria
Private Bag X 169
Pretoria
0001

 

 

The content of this article is the sole work of the author. No benefits of any form have been derived from any commercial party related directly or indirectly to the subject of this article.

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons